Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bonus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

5 resultados carregados para "trials"
Melanoma treatment mystery gets new answers from mathematical model
Melanoma treatment mystery gets new answers from mathematical model
New research from the University of Texas at Arlington helps explain a longstanding puzzle in melanoma treatment: why continuous targeted therapy performed better than planned on-and-off treatment schedules in clinical trials, despite promising laboratory studies of intermittent
DR Congo: Could a vaccine soon be available to the public?
DR Congo: Could a vaccine soon be available to the public?
The Ervebo vaccine has proved safe and effective against the more common Zaire strain of the Ebola virus, and World Health Organization experts say early data, notably from animal trials, suggest it may also offer some protection against the rarer Bundibugyo strain, which is spre
Real-world study provides new insights into safety of new Alzheimer's drug lecanemab
Real-world study provides new insights into safety of new Alzheimer's drug lecanemab
As new Alzheimer's drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them and whether they truly slow the disease outside tightly controlled studies.
Vitamin C may fight cancer — but not the way scientists once thought
Vitamin C may fight cancer — but not the way scientists once thought
Linus Pauling was widely mocked for claiming that vitamin C could fight cancer, especially after trials using vitamin C pills showed no benefit. Researchers now know that intravenous vitamin C reaches vastly higher concentrations and can behave more like an experimental cancer dr
Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.